Incyte (INCY) EPS (Basic) (QoQ) (2010 - 2026)
Powered by 
Analysis
Incyte (INCY) EPS (Basic) (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 10 | Incyte | 25.61 Bn | 21.07 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 92.06% |
| Mar 31, 2026 | -0.75% |
| Dec 31, 2025 | -29.28% |
| Sep 30, 2025 | 3.84% |
| Jun 30, 2025 | 155.63% |
| Mar 31, 2025 | -15.94% |
| Dec 31, 2024 | 75.79% |
| Sep 30, 2024 | 127.12% |
| Jun 30, 2024 | -369.81% |
| Mar 31, 2024 | -16.00% |
| Dec 31, 2023 | 17.64% |
| Sep 30, 2023 | -16.17% |
| Jun 30, 2023 | 836.67% |
| Mar 31, 2023 | -24.07% |
| Dec 31, 2022 | -74.72% |
| Sep 30, 2022 | -30.38% |
| Jun 30, 2022 | 324.27% |
| Mar 31, 2022 | -93.29% |
| Dec 31, 2021 | 210.84% |
| Sep 30, 2021 | 21.18% |